Literature DB >> 20180736

The INSURE method in preterm infants of less than 30 weeks' gestation.

Carlo Dani1, Iuri Corsini, Giovanna Bertini, Giulia Fontanelli, Simone Pratesi, Firmino F Rubaltelli.   

Abstract

OBJECTIVES: Our aim was to identify the clinical characteristics which could distinguish infants who can be managed with INSURE (intubatio-surfactant-extubation) method for preventing mechanical ventilation (MV) and which could predict INSURE success or failure.
METHODS: Inborn infants with gestational age <30 weeks were Infants were categorised into three groups: (1) infants who needed MV in the delivery room; (2) infants spontaneously breathing who were treated only with NCPAP; (3) infants who were treated with INSURE method.
RESULTS: We studied 125 infants: 30 (24%) required MV, 75 (60%) received INSURE treatment, and 20 (16%) were treated with NCPAP. Sixty-eight (91%) infants were successfully treated with the INSURE method. Infants in the success group had less severe RDS and less occurrence of sepsis and pneumothorax, lower mortality, and shorter duration of stay in the NICU than infants in the failure group. A birth weight <750 g, pO(2)/FiO(2) <218, and a/ApO(2) <0.44 at the first blood gas analysis were independent risk factor for INSURE failure.
CONCLUSIONS: The INSURE method can be applied to the majority of extremely preterm infants and is followed by a high percentage of success.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180736     DOI: 10.3109/14767050903572174

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  14 in total

1.  Endoscopic third ventriculostomy inpatient failure rates compared with shunting in post-hemorrhagic hydrocephalus of prematurity.

Authors:  Evan Luther; David McCarthy; Shaina Sedighim; Toba Niazi
Journal:  Childs Nerv Syst       Date:  2019-12-20       Impact factor: 1.475

2.  A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.

Authors:  Carlos G Guardia; Fernando R Moya; Sunil Sinha; Phillip D Simmons; Robert Segal; Jay S Greenspan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

3.  Surfactant Administration in Preterm Infants: Drug Development Opportunities.

Authors:  Genevieve Taylor; Wesley Jackson; Christoph P Hornik; Alec Koss; Sreekar Mantena; Kenya Homsley; Blair Gattis; Menefese Kudumu-Clavell; Reese Clark; P Brian Smith; Matthew M Laughon
Journal:  J Pediatr       Date:  2018-12-21       Impact factor: 6.314

4.  Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.

Authors:  Giovanni Vento; Roberta Pastorino; Luca Boni; Francesco Cota; Virgilio Carnielli; Filip Cools; Carlo Dani; Fabio Mosca; Jane Pillow; Graeme Polglase; Paolo Tagliabue; Anton H van Kaam; Maria Luisa Ventura; Milena Tana; Chiara Tirone; Claudia Aurilia; Alessandra Lio; Cinzia Ricci; Alessandro Gambacorta; Chiara Consigli; Danila D'Onofrio; Camilla Gizzi; Luca Massenzi; Viviana Cardilli; Alessandra Casati; Roberto Bottino; Federica Pontiggia; Elena Ciarmoli; Stefano Martinelli; Laura Ilardi; Mariarosa Colnaghi; Piero Giuseppe Matassa; Valentina Vendettuoli; Paolo Villani; Francesca Fusco; Diego Gazzolo; Alberto Ricotti; Federica Ferrero; Ilaria Stasi; Rosario Magaldi; Gianfranco Maffei; Giuseppe Presta; Roberto Perniola; Francesco Messina; Giovanna Montesano; Chiara Poggi; Lucio Giordano; Enza Roma; Carolina Grassia; Gaetano Ausanio; Fabrizio Sandri; Giovanna Mescoli; Francesco Giura; Giampaolo Garani; Agostina Solinas; Maria Lucente; Gabriella Nigro; Antonello Del Vecchio; Flavia Petrillo; Luigi Orfeo; Lidia Grappone; Lorenzo Quartulli; Antonio Scorrano; Hubert Messner; Alex Staffler; Giancarlo Gargano; Eleonora Balestri; Stefano Nobile; Caterina Cacace; Valerio Meli; Sara Dallaglio; Betta Pasqua; Loretta Mattia; Eloisa Gitto; Marcello Vitaliti; Maria Paola Re; Stefania Vedovato; Alessandra Grison; Alberto Berardi; Francesco Torcetta; Isotta Guidotti; Sandra di Fabio; Eugenia Maranella; Isabella Mondello; Stefano Visentin; Francesca Tormena
Journal:  Trials       Date:  2016-08-18       Impact factor: 2.279

5.  High Flow Nasal Cannulae versus Nasal Continuous Positive Airway Pressure in Neonates with Respiratory Distress Syndrome Managed with INSURE Method: A Randomized Clinical Trial.

Authors:  Maliheh Kadivar; Ziba Mosayebi; Nosrat Razi; Shahin Nariman; Razieh Sangsari
Journal:  Iran J Med Sci       Date:  2016-11

Review 6.  Golden hour of neonatal life: Need of the hour.

Authors:  Deepak Sharma
Journal:  Matern Health Neonatol Perinatol       Date:  2017-09-19

7.  Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial.

Authors:  Bita Najafian; Hamidreza Karimi-Sari; Mohammad Hossein Khosravi; Niloofar Nikjoo; Sobhan Amin; Majid Shohrati
Journal:  Contemp Clin Trials Commun       Date:  2016-04-13

8.  Intubation-Surfactant: Extubation on Continuous Positive Pressure Ventilation. Who are the Best Candidates?

Authors:  Maria Livia Ognean; Silvia-Maria Stoicescu; Oana Boantă; Leonard Năstase; Carmen Gliga; Manuela Cucerea
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-05-09

9.  Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study.

Authors:  Nis Brix; Anna Sellmer; Morten Søndergaard Jensen; Linda Vad Pedersen; Tine Brink Henriksen
Journal:  BMC Pediatr       Date:  2014-06-19       Impact factor: 2.125

10.  Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants.

Authors:  Ji Won Koh; Jong-Wan Kim; Young Pyo Chang
Journal:  Korean J Pediatr       Date:  2018-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.